Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Risk assessment in Stage II colorectal cancer.

Marshall JL.

Oncology (Williston Park). 2010 Jan;24(1 Suppl 1):9-13.

2.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
3.

Microsatellite instability in the management of stage II colorectal patients.

Strâmbu V, Garofil D, Pop F, Radu P, Brătucu M, Iorga C, Iorga R, Pasnicu C, Ion A, Popa F.

Chirurgia (Bucur). 2013 Nov-Dec;108(6):816-21.

4.

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S.

N Engl J Med. 2003 Jul 17;349(3):247-57.

5.

Adjuvant therapy for colon cancer.

Aranha O, Benson AB 3rd.

Curr Gastroenterol Rep. 2007 Oct;9(5):415-21. Review.

PMID:
17991344
6.

Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials.

Wu X, Zhang J, He X, Wang C, Lian L, Liu H, Wang J, Lan P.

J Gastrointest Surg. 2012 Mar;16(3):646-55. doi: 10.1007/s11605-011-1682-8. Epub 2011 Dec 23. Review.

PMID:
22194062
7.

Adjuvant chemotherapy of stage III colon cancer.

Benson AB 3rd.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S74-7.

PMID:
16399437
8.

Adjuvant therapy for completely resected stage II colon cancer.

Figueredo A, Coombes ME, Mukherjee S.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005390. doi: 10.1002/14651858.CD005390.pub2. Review.

PMID:
18646127
9.

Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.

Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S.

Cancer Prev Control. 1997 Dec;1(5):379-92.

PMID:
9765760
10.

Current status of adjuvant therapy for colorectal cancer.

O'Connell MJ.

Oncology (Williston Park). 2004 May;18(6):751-5; discussion 755-8. Review.

11.

Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Lin CC, Lin JK, Chang SC, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC.

Int J Colorectal Dis. 2009 Jun;24(6):665-76. doi: 10.1007/s00384-009-0634-1. Epub 2009 Feb 24.

PMID:
19238405
12.

Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors.

Cascinu S, Georgoulias V, Kerr D, Maughan T, Labianca R, Ychou M.

Ann Oncol. 2003;14 Suppl 2:ii25-9. Review.

13.

Therapy for early-stage colorectal cancer.

Peeters M, Haller DG.

Oncology (Williston Park). 1999 Mar;13(3):307-15; discussion 315-7, 320-1. Review.

14.

The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.

Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Pons E, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21.

PMID:
18722765
15.
16.

Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.

Tejpar S, Saridaki Z, Delorenzi M, Bosman F, Roth AD.

J Natl Cancer Inst. 2011 Jun 8;103(11):841-4. doi: 10.1093/jnci/djr170. Epub 2011 May 19. No abstract available.

17.

DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.

Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Kim GP, Yothers G, Allegra C, Moore MJ, Gallinger S, Sargent DJ.

J Natl Cancer Inst. 2011 Jun 8;103(11):863-75. doi: 10.1093/jnci/djr153. Epub 2011 May 19. Erratum in: J Natl Cancer Inst. 2011 Nov 2;103(21):1639. Kim, George P [added].

19.

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.

McCleary NJ, Meyerhardt JA, Green E, Yothers G, de Gramont A, Van Cutsem E, O'Connell M, Twelves CJ, Saltz LB, Haller DG, Sargent DJ.

J Clin Oncol. 2013 Jul 10;31(20):2600-6. doi: 10.1200/JCO.2013.49.6638. Epub 2013 Jun 3.

20.

Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.

Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S.

Cancer Prev Control. 1997 Oct;1(4):304-19. Erratum in: Cancer Prev Control 1997 Dec;1(5):351.

PMID:
9765754
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk